BridgeBio Pharma, Inc. — SCHEDULE 13G/A Filings
3 SCHEDULE 13G/A filings on record
This page lists all SCHEDULE 13G/A filings submitted to the SEC by BridgeBio Pharma, Inc. (BBIO), sorted by most recent first. Each row links to the full filing on EdgarLookup. BridgeBio Pharma, Inc. has filed 3 SCHEDULE 13G/A documents with the SEC since 2018. To view all SEC filings by BridgeBio Pharma, Inc., see the full filings list.
All
10-K
10-Q
144
3
4
4/A
424B3
424B4
424B5
424B7
425
5
5/A
8-A12B
8-K
ARS
CERT
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEFM14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3ASR
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-000828 | Mar 26, 2026 | — |
| SCHEDULE 13G/A | — | 0000932471-25-000753 | Jul 29, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-020045 | Feb 13, 2025 | — |